DOI:
10.1055/s-00035331
Revista Urología Colombiana / Colombian Urology Journal
LinksClose Window
References
Böhm M, Baumhäkel M, Teo K. , et al; ONTARGET/TRANSCEND Erectile Dysfunction Substudy Investigators.
Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials.
Circulation 2010;
121 (12) 1439-1446
We do not assume any responsibility for the contents of the web pages of other providers.